AI-generated summary
The authors report an exploratory, sham-controlled randomized trial of twice-daily photobiomodulation LED therapy in 40 children aged 8 to 12 with myopia over 3 months. A small reduction in axial elongation was seen in the left eye only, while adjusted participant-level analyses were not significant. The authors state the small sample and short follow-up preclude definitive efficacy or long-term safety conclusions.
- Participants
- 40
- Who or what was studied
- Children aged 8 to 12 years with myopia
- Limits stated in the abstract
- The authors note the small sample, a unilateral nominal finding, nonsignificant adjusted analyses, visual-acuity changes, and short follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Photobiomodulation, Myopia, Sham, Repeated low-level red light, Confidence interval, Trial registration, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.